ישראל - עברית - Ministry of Health

rafa laboratories ltd - pyridostigmine bromide - טבליה - pyridostigmine bromide 30 mg - pyridostigmine - pyridostigmine - pyridostigmine belongs to the cholinesterase inhibitor group and is indicated for the treatment of myasthenia gravis.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - pyridostigmine bromide - טבליה - pyridostigmine bromide 60 mg - pyridostigmine - pyridostigmine - pyridostigmine belons to the cholinesterase inhibitor group and is indicated for the treatment of myasthenia gravis.

ישראל - עברית - Ministry of Health

megapharm ltd - pyridostigmine bromide - דרז'ה - pyridostigmine bromide 60.0 mg - pyridostigmine - pyridostigmine - treatment of myasthenia gravis.

ישראל - עברית - Ministry of Health

novartis israel ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 1.5 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.

ישראל - עברית - Ministry of Health

novartis israel ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 3 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.

ישראל - עברית - Ministry of Health

novartis israel ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 4.5 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementiasymptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.

ישראל - עברית - Ministry of Health

novartis israel ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 6 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.

ישראל - עברית - Ministry of Health

novartis israel ltd - rivastigmine - מדבקות - rivastigmine 9.5 mg/day - rivastigmine

ישראל - עברית - Ministry of Health

novartis israel ltd - rivastigmine - מדבקות - rivastigmine 27 mg - rivastigmine

ישראל - עברית - Ministry of Health

novartis israel ltd - rivastigmine - מדבקות - rivastigmine 4.6 mg/day - rivastigmine